topSkip to main content

Menu, Secondary

Menu Trigger


University of California San Diego

At the University of California San Diego, we constantly push boundaries and challenge expectations. Established in 1960, UC San Diego has been shaped by exceptional scholars who aren’t afraid to take risks and redefine conventional wisdom. Today, as one of the top 15 research universities in the world, we are driving innovation and change to advance society, propel economic growth and make our world a better place.

Learn more at

Engineers created a new type of battery that weaves two promising battery sub-fields into a single battery. The battery uses both a solid state electrolyte and an all-silicon anode, making it a silicon all-solid-state battery. The initial rounds of tests show that the new battery is safe, long lasting, and energy dense. It holds promise for a wide range of applications from grid storage to electric vehicles.
Cardiovascular physicians with UC San Diego Health have joined an international clinical trial utilizing a new Extravascular Implantable Cardioverter-Defibrillator (EV ICD) system to help treat sudden cardiac arrest.
In a new study from University of California San Diego School of Medicine, researchers have confirmed that patients taking statin medications had a 41 percent lower risk of in-hospital death from COVID-19.
Nationwide team encompasses multiple agencies to create new “GHub” tool to catalog the ice sheets of Greenland and Antarctica
Researchers at University of California San Diego School of Medicine have begun a pilot clinical trial to test the efficacy of using ultrasound to stimulate the spleen and reduce COVID-19-related inflammation, decreasing the length of hospital stays.
UC San Diego scientists are using remote sensing to create detailed maps of groundwater resources in the San Joaquin Valley and to determine when and where groundwater in the region is being recharged.
A new study led by neurobiologists at the University of California San Diego and their colleagues can help form the basis for improving therapeutic strategies for precise symptoms of Parkinson’s at various levels of disease progression.
Researchers from UC San Diego have found that experimental therapies that block an enzyme produced by parasites causing heart disease may also be effective in treating COVID-19.
UC San Diego and UCLA researchers emphasized the critical importance of continued public health mitigation measures even in highly vaccinated environments after a study found COVID-19 infections among vaccinated health care workers.